Asthma
COPD
Pulmonary
COPD: Page 4
FDA clears first over-the-counter fingertip pulse oximeter
Device provides patients with COPD a way to assess blood oxygen levels.
February 28, 2024
Reproductive factors in women linked to heightened COPD risk
Menstruation, miscarriage, infertility and other factors cited in study.
February 19, 2024
Patients with COPD could see improved health from lifestyle changes
Researchers find behavior change interventions lead to health benefits.
February 19, 2024
Sponsored
Prospects across the asthma market
Ascend Media
The 2024 Asthma Pipeline Insight report provides global coverage of existing and emerging asthma therapies, as well as updates on future growth potential.
March 25, 2024
Pulmonary rehab for patients with COPD is difficult to access
Study finds millions are more than an hour away from needed care.
February 13, 2024
Cadmium causes deleterious stress in lung cells of patients with COPD
Research points the way to potential therapeutic targets.
February 13, 2024
Novel therapeutic candidate targets COPD
Monoclonal antibody shows promise in early data.
February 2, 2024
Sponsored
Where there’s fire, there’s smoke
Ascend Media
CHEST Advocates examines the effects of climate change on lung health.
March 25, 2024
Gum disease can aggravate COPD
Study reveals how periodontitis activates immune cells associated with aggravated progression of COPD.
January 25, 2024
COPD patients may benefit from increased access to palliative care
Study finds one change can dramatically give care to more hospitalized patients.
January 25, 2024
FDA authorizes Florida drug importation program
The program would apply only to certain drugs, including those for asthma and COPD.
January 16, 2024
Sponsored
Prospects across the asthma market
Ascend Media
The 2024 Asthma Pipeline Insight report provides global coverage of existing and emerging asthma therapies, as well as updates on future growth potential.
March 25, 2024
2024 GOLD report emphasizes vaccines for patients with COPD
People with COPD should receive all recommended vaccines.
January 16, 2024
Dupixent (dupilumab) reduced COPD exacerbations in second phase 3 trial
Results could accelerate FDA approval with the potential to become the first approved biologic for COPD.
January 10, 2024
Study for revefenacin inhaler fails to meet goal
Study showed no difference between YUPELRI and Spiriva inhalers.
January 10, 2024
Previous Page
Page 4 of 8
Next Page
Most Popular
Promising mRNA drug fares well in phase 1 trial
A tale of two insurers
A microscopic feat of engineering
Using acetaminophen to help treat sepsis patients
FDA approves ensifentrine for COPD maintenance treatment
FDA grants clearance for clinical deterioration software